Provided by Tiger Fintech (Singapore) Pte. Ltd.

Acadia

18.77
-0.1800-0.95%
Post-market: 18.770.00000.00%16:11 EDT
Volume:1.16M
Turnover:21.78M
Market Cap:2.46B
PE:113.37
High:19.05
Open:19.05
Low:18.61
Close:18.95
Loading ...

Acadia Realty Trust expected to post earnings of 9 cents a share - Earnings Preview

Reuters
·
13 hours ago

3 Stocks That Could Be Trading At Estimated Discounts Of Up To 49.8%

Simply Wall St.
·
16 hours ago

Great Lakes Dredge announces launch of the Acadia

TIPRANKS
·
23 Jul

3 Stocks That May Be Trading Below Their Estimated Value In July 2025

Simply Wall St.
·
22 Jul

3 Stocks Estimated To Be Undervalued By Up To 27.5% Offering Investment Opportunities

Simply Wall St.
·
12 Jul

Shoals Technologies Group Leads These 3 Stocks Estimated Below Intrinsic Value

Simply Wall St.
·
05 Jul

Acadia Realty Trust to Announce Second Quarter 2025 Earnings Results

Reuters
·
02 Jul

Acadia Pharmaceuticals Stock Price Undervalues Potential Market Opportunity of Nuplazid, Daybue, RBC Says

MT Newswires Live
·
26 Jun

Acadia Realty Trust EVP and CIO Reginald Livingston Reports Disposal of Common Shares

Reuters
·
14 Jun

Acadia court ruling supports Nuplazid exclusivity into 2030, says Mizuho

TIPRANKS
·
11 Jun

Acadia Pharmaceuticals Wins Patent Case for NUPLAZID

TIPRANKS
·
11 Jun

Acadia Realty Trust to Participate in NAREIT's REITweek®: 2025 Investor Conference

Reuters
·
31 May

Acadia Pharmaceuticals Holds 2025 Annual Stockholder Meeting

TIPRANKS
·
30 May

Acadia Realty (AKR) Gets a Buy from Truist Financial

TIPRANKS
·
28 May

Deutsche upgrades Acadia to Buy on new ‘valuation floor’

TIPRANKS
·
21 May

Acadia Pharmaceuticals upgraded to Buy from Hold at Deutsche Bank

TIPRANKS
·
21 May

Acadia Pharmaceuticals price target raised to $28 from $24 at BMO Capital

TIPRANKS
·
19 May

Acadia Pharmaceuticals price target raised to $23 from $20 at Mizuho

TIPRANKS
·
19 May

Acadia Pharmaceuticals price target raised to $31 from $28 at Baird

TIPRANKS
·
19 May

Acadia Pharmaceuticals Wins Patent Case Involving Parkinson's Disease Treatment

Dow Jones
·
17 May